Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma

N-803-BCG combination shows promising results in BCG-unresponsive NMIBC

Sacituzumab goviteca provides clinically meaningful PFS benefit for hormone receptor HR+/HER2‐ advanced breast cancer patients

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

ASCO and WHO to collaborate on quality indicators for cancer facilities

Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer

Cancer Services Delivery: Focus on India

Information sharing experiences of professionals looking after children with cancer

Pre-operative risk factors associated with peri-operative psychiatric diagnosis in oral cancer patients